MSN Laboratories Private Limited
UkraineAll drugs from this manufacturer
-
The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed hormone-sensitive (high risk), low-volume castration-resistant after inadequate androgen deprivation therapy, as well as progressive castration-resistant during or after docetaxel chemotherapy.
Dosage form: tablets
Active substance Dosage abiraterone 250 mg ATC: L02BX03
-
The drug is intended for the treatment of adult patients with certain subtypes of myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML).
Dosage form: powder for injection solution
Active substance Dosage azacitidine 100 mg ATC: L01BC07
-
The drug is prescribed for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.
Dosage form: powder for injection, lyophilized for preparation of solution for injection
Active substance Dosage bortezomib 3.5 mg ATC: L01XG01
-
The drug is intended for the treatment of premature ejaculation in adult men aged 18 to 64 years.
Dosage form: tablets, film-coated
Active substance Dosage dapoxetine 30 mg ATC: G04BX14
-
The drug is intended for the treatment of premature ejaculation in adult men aged 18 to 64 years.
Dosage form: tablets, film-coated
Active substance Dosage dapoxetine 60 mg ATC: G04BX14
-
The drug is used as part of combination therapy to prepare for stem cell transplantation in hematological diseases, as well as for the treatment of solid tumors in adults and children.
Dosage form: powder for injection, lyophilized for preparation of solution for injection
Active substance Dosage thiotepa 100 mg ATC: L01AC01